{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:31:50Z","timestamp":1769729510610,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Mycology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.mycmed.2023.101414","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T17:27:44Z","timestamp":1690133264000},"page":"101414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature"],"prefix":"10.1016","volume":"33","author":[{"given":"Vikram","family":"Damaraju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inderpaul","family":"Singh Sehgal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alka","family":"Khadwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanjit","family":"Bal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaprakash Mandya","family":"Rudramurthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0410-8468","authenticated-orcid":false,"given":"Valliappan","family":"Muthu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mycmed.2023.101414_bib0001","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/cid\/cix687","article-title":"Call for action: invasive fungal infections associated with ibrutinib and other small molecule kinase inhibitors targeting immune signaling pathways","volume":"66","author":"Chamilos","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101414_bib0002","doi-asserted-by":"crossref","first-page":"e985","DOI":"10.1016\/j.clml.2021.07.022","article-title":"Real-world characteristics and outcome of patients treated with single-agent ibrutinib for chronic lymphocytic leukemia in Spain (IBRORS-LLC study)","volume":"21","author":"Abrisqueta","year":"2021","journal-title":"Clin Lymph Myelom Leuke"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101414_bib0003","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/ejh.13020","article-title":"Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies","volume":"100","author":"Tillman","year":"2018","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101414_bib0004","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/jim-2016-000120.93","article-title":"ID: 54: cutaneous mucormycosis in a patient with chronic lymphocytic leukemia: a pharmacological dilemma","volume":"64","author":"Figueroa Castro","year":"2016","journal-title":"J Investigat Med"},{"key":"10.1016\/j.mycmed.2023.101414_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-221473","article-title":"Isolated cerebral mucormycosis caused by Rhizomucor pusillus","volume":"2017","author":"Farid","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101414_bib0006","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1111\/ajd.12615","article-title":"Successful use of Bruton's kinase inhibitor, ibrutinib, to control paraneoplastic pemphigus in a patient with paraneoplastic autoimmune multiorgan syndrome and chronic lymphocytic leukaemia","volume":"58","author":"Lee","year":"2017","journal-title":"Austral J Dermatol"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101414_bib0007","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s15010-018-1138-0","article-title":"Invasive fungal infections associated with prior respiratory viral infections in immunocompromised hosts","volume":"46","author":"Ajmal","year":"2018","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101414_bib0008","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hon.2387","article-title":"Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma","volume":"36","author":"Kreiniz","year":"2018","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.mycmed.2023.101414_bib0009","article-title":"Pulmonary Mucormycosis in Chronic Lymphocytic Leukemia and Neutropenia","volume":"2018","author":"Mir","year":"2018","journal-title":"Case Rep Infect Dis"},{"issue":"9","key":"10.1016\/j.mycmed.2023.101414_bib0010","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/cix1058","article-title":"Invasive fungal sinusitis due to mucor species in a patient on ibrutinib","volume":"66","author":"Serota","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101414_bib0011","doi-asserted-by":"crossref","first-page":"62","DOI":"10.14740\/wjon1099w","article-title":"Cutaneous mucormycosis following a bullous pemphigoid flare in a chronic lymphocytic leukemia patient on ibrutinib","volume":"9","author":"Stein","year":"2018","journal-title":"World J Oncol"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101414_bib0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/10428194.2018.1485913","article-title":"Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinib","volume":"60","author":"Cummins","year":"2019","journal-title":"Leukem Lymph"},{"issue":"2","key":"10.1016\/j.mycmed.2023.101414_bib0013","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cmi.2018.10.004","article-title":"Disseminated mucormycosis due to Lichtheimia corymbifera during ibrutinib treatment for relapsed chronic lymphocytic leukaemia: a case report","volume":"25","author":"Grossi","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101414_bib0014","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40463-019-0376-1","article-title":"The infectious thyroid nodule: a case report of mucormycosis associated with ibrutinib therapy","volume":"48","author":"Mascarella","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101414_bib0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cmi.2019.01.016","article-title":"Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemia","volume":"25","author":"Pouvaret","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.mycmed.2023.101414_bib0016","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1038\/s41375-019-0481-1","article-title":"Incidence of opportunistic infections during ibrutinib treatment for B-cell malignancies","volume":"33","author":"Rogers","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.mycmed.2023.101414_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.mmcr.2019.12.005","article-title":"Multi-fungal sepsis and mucormycosis of the central nervous system in a patient treated with ibrutinib, a case report and review of the literature","volume":"27","author":"Fehr","year":"2020","journal-title":"Med Mycol Case Rep"},{"key":"10.1016\/j.mycmed.2023.101414_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01132","article-title":"Post-traumatic cutaneous mucormycosis","volume":"24","author":"Hoesly","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.mycmed.2023.101414_bib0019","doi-asserted-by":"crossref","first-page":"e01120","DOI":"10.1016\/j.idcr.2021.e01120","article-title":"Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib","volume":"24","author":"Sittig","year":"2021","journal-title":"IDCases"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101414_bib0020","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-2533","article-title":"A case report of the metagenomics next-generation sequencing for early detection of central nervous system mucormycosis with successful rescue in patient with recurrent chronic lymphocytic leukemia","volume":"10","author":"Zhang","year":"2022","journal-title":"Ann Transl Med"},{"issue":"17","key":"10.1016\/j.mycmed.2023.101414_bib0021","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1182\/blood-2017-11-818286","article-title":"Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib","volume":"131","author":"Ghez","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101414_bib0022","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mycmed.2023.101414_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.630942","article-title":"Comparative analysis of BTK inhibitors and mechanisms underlying adverse effects","volume":"9","author":"Estupi\u00f1\u00e1n","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"10.1016\/j.mycmed.2023.101414_bib0024","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1080\/10428194.2020.1797017","article-title":"Ibrutinib and invasive fungal infections: the known, the unknown and the known unknowns","volume":"61","author":"Reynolds","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101414_bib0025","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/j.transproceed.2014.05.033","article-title":"Fungal infection by Mucorales order in lung transplantation: 4 case reports","volume":"46","author":"Neto","year":"2014","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101414_bib0026","first-page":"3221","article-title":"European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia","volume":"73","author":"Maertens","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101414_bib0027","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/QCO.0000000000000611","article-title":"Azole antifungals and new targeted therapies for hematological malignancy","volume":"32","author":"Lindsay","year":"2019","journal-title":"Curr Opin Infect Dis"},{"issue":"4","key":"10.1016\/j.mycmed.2023.101414_bib0028","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.cmi.2020.12.035","article-title":"Has the mortality from pulmonary mucormycosis changed over time? A systematic review and meta-analysis","volume":"27","author":"Muthu","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.mycmed.2023.101414_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00124-4","article-title":"Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India","author":"Muthu","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.mycmed.2023.101414_bib0030","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mycmed.2023.101414_bib0031","doi-asserted-by":"crossref","DOI":"10.1111\/myc.13591","article-title":"Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): results of an open-label randomized controlled trial","author":"Muthu","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2023.101414_bib0032","article-title":"Isolated tracheobronchial mucormycosis: report of a case and systematic review of literature","author":"Damaraju","year":"2022","journal-title":"Mycoses"},{"issue":"1","key":"10.1016\/j.mycmed.2023.101414_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2021.101228","article-title":"Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: mind the diagnostic gap","volume":"32","author":"Crone","year":"2022","journal-title":"J Mycol Med"},{"issue":"6","key":"10.1016\/j.mycmed.2023.101414_bib0034","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/myc.13263","article-title":"Role of flexible bronchoscopy in the diagnosis of invasive fungal infections","volume":"64","author":"Muthu","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.mycmed.2023.101414_bib0035","article-title":"Endobronchial mucormycosis: a rare clinical entity diagnosed by endobronchial cryobiopsy","volume":"37","author":"Bajwa","year":"2022","journal-title":"Respir Med Case Rep"}],"container-title":["Journal of Medical Mycology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1156523323000586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T05:23:12Z","timestamp":1761110592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1156523323000586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1156523323000586"],"URL":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101414","relation":{},"ISSN":["1156-5233"],"issn-type":[{"value":"1156-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ibrutinib and tracheal mucormycosis: A case report and systematic review of literature","name":"articletitle","label":"Article Title"},{"value":"Journal of Medical Mycology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mycmed.2023.101414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SFMM. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101414"}}